LIDOCAINE HYDROCHLORIDE AND DEXTROSE
NDC 51662-1657, LIDOCAINE HYDROCHLORIDE AND DEXTROSE, injection, solution, from HF Acquisition Co LLC, DBA HealthFirst.
- Product NDC
- 51662-1657
- Status
- Listed
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA018461
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1657 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIDOCAINE HYDROCHLORIDE8 mg/mL
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51662-1657-1 | 51662165701 | 250 mL in 1 BAG (51662-1657-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1bf999b5-e290-dcbd-e063-6294a90a2bab
Use it
Look up 51662-1657 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1657 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51662-1657. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.